Dr. Karin Immergluck, Associate Director of Licensing at UC San Francisco’s Office of Innovation, Technology and Alliances, describes intellectual property (IP) and its role in supporting the development of novel technologies invented by university researchers. In healthcare product development, IP represents an invaluable asset for innovators by creating critical barriers to entry for competitors. Without a clear and tangible hurdle to entry, even the most beneficial product will struggle to attract the investment and partnerships crucial to the development and commercialization of healthcare products. Sign up to receive updates on videos that highlight how Dr. Immergluck and her team support UC San Francisco researchers to maximize the value of their inventions.
- Date September 26, 2013
- Tags Development Plan